Salarius Pharmaceuticals, Inc.SLRX

Market cap

$1.43M

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	-	-	-	-	10	4	11	29	12	6	2
Prepaid expenses and other current assets	370,396	908,574	925,983	777,102	162,088	955,899	822,050	949,215	803,373	619,763	553,034
Total current assets	34	92	62	35	10	5	16	30	15	7	3
Other assets	50,000	-	64,800	-	-	308,674	247,113	185,994	130,501	66,850	35,412
Total assets	36	95	63	35	10	14	25	41	15	7	3
Accounts payable	578,653	875,646	1	2	342,530	2	2	2	3	602,853	936,994
Accrued expenses and other current liabilities	-	-	-	-	-	160,783	383,138	553,269	1	406,745	352,419
Notes payable	-	-	-	-	-	502,332	1	-	-	0	0
Total liabilities	1	3	4	6	1	3	3	2	4	1	2
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	221	1,574	1,678	1,780	1,807	451	2,381	4,524	225	393	144
Additional paid-in capital	1	129	136	140	142	23	42	71	74	82	83
Accumulated deficit	-8,010,860	-37,152,490	-76,645,613	-111,079,275	-132,961,275	-12,076,700	-19,428,954	-32,197,192	-63,805,148	-76,347,841	-81,923,618
Total stockholders' equity	-6,538,340	92	59	29	9	11	22	39	10	5	2
Total liabilities and stockholders' equity	36	95	63	35	10	14	25	41	15	7	3